Zobrazeno 1 - 10
of 20
pro vyhledávání: '"García-Cuesta EM"'
Autor:
García-Cuesta EM; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Martínez P; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Selvaraju K; Division of Diagnostics and Specialist Medicine, Department of Health, Medical and Caring Sciences, Linköping University, Linköping, Sweden., Ulltjärn G; Division of Diagnostics and Specialist Medicine, Department of Health, Medical and Caring Sciences, Linköping University, Linköping, Sweden., Gómez Pozo AM; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain., D'Agostino G; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Gardeta S; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Quijada-Freire A; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Blanco Gabella P; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain., Roca C; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain., Hoyo DD; Biocomputing Unit, Centro Nacional de Biotecnología (CNB-CSIC), Campus de Cantoblanco, Madrid, Spain., Jiménez-Saiz R; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain.; Department of Immunology, Instituto de Investigación Sanitaria Hospital Universitario de La Princesa (IIS-Princesa), Madrid, Spain.; Department of Medicine, McMaster Immunology Research Centre (MIRC), Schroeder Allergy and Immunology Research Institute, McMaster University, Hamilton, Canada.; Faculty of Experimental Sciences, Universidad Francisco de Vitoria (UFV), Madrid, Spain., García-Rubia A; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain., Soler Palacios B; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Lucas P; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Ayala-Bueno R; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Santander Acerete N; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Carrasco Y; B Lymphocyte Dynamics, Department of Immunology and Oncology, Centro Nacional de Biotecnología (CNB)/CSIC, Campus de Cantoblanco, Madrid, Spain., Oscar Sorzano C; Biocomputing Unit, Centro Nacional de Biotecnología (CNB-CSIC), Campus de Cantoblanco, Madrid, Spain., Martinez A; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain.; Neurodegenerative Diseases Biomedical Research Network Center (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Campillo NE; Centro de Investigaciones Biológicas Margarita Salas (CIB-CSIC), Madrid, Spain., Jensen LD; Division of Diagnostics and Specialist Medicine, Department of Health, Medical and Caring Sciences, Linköping University, Linköping, Sweden., Rodriguez Frade JM; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Santiago C; X-ray Crystallography Unit, Department of Macromolecules Structure, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain., Mellado M; Chemokine Signaling group, Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Campus de Cantoblanco, Madrid, Spain.
Publikováno v:
ELife [Elife] 2024 Sep 09; Vol. 13. Date of Electronic Publication: 2024 Sep 09.
Autor:
Cayuela López A; Biocomputing Unit, National Centre for Biotechnology, Cantoblanco, Madrid, Spain., García-Cuesta EM; Department of Immunology and Oncology, National Centre for Biotechnology, Cantoblanco, Madrid, Spain., Gardeta SR; Department of Immunology and Oncology, National Centre for Biotechnology, Cantoblanco, Madrid, Spain., Rodríguez-Frade JM; Department of Immunology and Oncology, National Centre for Biotechnology, Cantoblanco, Madrid, Spain., Mellado M; Department of Immunology and Oncology, National Centre for Biotechnology, Cantoblanco, Madrid, Spain., Gómez-Pedrero JA; Applied Optics Complutense Group, Faculty of Optics and Optometry, University Complutense of Madrid, Madrid, Spain., S Sorzano CO; Biocomputing Unit, National Centre for Biotechnology, Cantoblanco, Madrid, Spain.
Publikováno v:
Biological imaging [Biol Imaging] 2023 Oct 11; Vol. 3, pp. e18. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).
Autor:
Castellano E; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., Samba C; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., Esteso G; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., Simpson L; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States., Vendrame E; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States., García-Cuesta EM; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., López-Cobo S; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., Álvarez-Maestro M; Urology Department, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.; Urology Unit, Infanta Sofia Hospital, Madrid, Spain., Linares A; Urology Unit, Infanta Sofia Hospital, Madrid, Spain., Leibar A; Urology Unit, Infanta Sofia Hospital, Madrid, Spain., Ranganath T; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States., Reyburn HT; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain., Martínez-Piñeiro L; Urology Department, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain.; Urology Unit, Infanta Sofia Hospital, Madrid, Spain., Blish C; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.; Chan Zuckerberg Biohub, San Francisco, CA, United States., Valés-Gómez M; Department of Immunology and Oncology, National Centre for Biotechnology (CNB) Spanish National Research Council (CSIC), Madrid, Spain.; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Sep 15; Vol. 13, pp. 970931. Date of Electronic Publication: 2022 Sep 15 (Print Publication: 2022).
Autor:
Gardeta SR; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., García-Cuesta EM; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., D'Agostino G; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Soler Palacios B; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Quijada-Freire A; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Lucas P; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Bernardino de la Serna J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Central Laser Facility, Rutherford Appleton Laboratory, Medical Research Council-Research Complex at Harwell, Science and Technology Facilities Council, Harwell, United Kingdom.; National Institute for Health and Care Research Imperial Biomedical Research Center, London, United Kingdom., Gonzalez-Riano C; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain., Barbas C; Metabolomic and Bioanalysis Center (CEMBIO), Pharmacy Faculty, Centro de Estudios Universitarios Universities, Madrid, Spain., Rodríguez-Frade JM; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain., Mellado M; Chemokine Signaling Group, Department of Immunology and Oncology, National Center for Biotechnology/Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jul 12; Vol. 13, pp. 925559. Date of Electronic Publication: 2022 Jul 12 (Print Publication: 2022).
Autor:
Bovolenta ER; Immune System Development and Function Unit, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28049 Madrid, Spain., García-Cuesta EM; Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, 28049 Madrid, Spain., Horndler L; Immune System Development and Function Unit, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28049 Madrid, Spain., Ponomarenko J; Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, 08003 Barcelona, Spain.; Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08002 Barcelona, Spain., Schamel WW; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.; Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.; Department of Immunology, Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.; Centre for Chronic Immunodeficiency, University Clinics and University of Freiburg, 79110 Freiburg, Germany., Mellado M; Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, 28049 Madrid, Spain., Castro M; Grupo Interdisciplinar de Sistemas Complejos, Escuela Técnica Superior de Ingeniería, Universidad Pontificia Comillas de Madrid, 28015 Madrid, Spain., Abia D; Servicio de Bioinformática, Centro Biología Molecular Severo Ochoa, CSIC/UAM, 28049 Madrid, Spain., van Santen HM; Immune System Development and Function Unit, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), 28049 Madrid, Spain.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 May 31; Vol. 119 (22), pp. e2201907119. Date of Electronic Publication: 2022 May 26.
Autor:
García-Cuesta EM; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Rodríguez-Frade JM; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Gardeta SR; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.; Department of Molecular Biosciences, Universidad Autónoma de Madrid, E-28049 Madrid, Spain., D'Agostino G; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Martínez P; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Soler Palacios B; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Cascio G; Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021., Wolf T; Institute of Microbiology, ETH Zürich, 8092 Zürich, Switzerland., Mateos N; Institut de Ciencies Fotoniques, Barcelona Institute of Science and Technology, E-08860 Barcelona, Spain., Ayala-Bueno R; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Santiago CA; X-ray Crystallography Unit, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Lucas P; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain., Llorente L; 12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain., Allende LM; 12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain., González-Granado LI; 12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.; Department of Public Health School of Medicine, School of Medicine Universidad Complutense de Madrid, E-28040 Madrid, Spain., Martín-Cófreces N; Immunology Service, Hospital Universitario de la Princesa, UAM, IIS-IP, E-28006 Madrid, Spain.; Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, E-28029 Madrid, Spain.; Centro de Investigación Básica en Red cardiovascular, E-28029 Madrid, Spain., Roda-Navarro P; 12 de Octubre Health Research Institute (imas12), E-28012 Madrid, Spain.; Department of Immunology, Ophthalmology, and ENT, School of Medicine, Universidad Complutense de Madrid, E-28040 Madrid, Spain., Sallusto F; Institute of Microbiology, ETH Zürich, 8092 Zürich, Switzerland.; Institute for Research in Biomedicine, Bellinzona, Università della Svizzera Italiana, 6900 Lugano, Switzerland., Sánchez-Madrid F; Immunology Service, Hospital Universitario de la Princesa, UAM, IIS-IP, E-28006 Madrid, Spain.; Area of Vascular Pathophysiology, Laboratory of Intercellular Communication, Fundación Centro Nacional de Investigaciones Cardiovasculares-Carlos III, E-28029 Madrid, Spain.; Centro de Investigación Básica en Red cardiovascular, E-28029 Madrid, Spain., García-Parajo MF; Institut de Ciencies Fotoniques, Barcelona Institute of Science and Technology, E-08860 Barcelona, Spain.; Institutió Catalana de Recerca i Estudis Avançats, E-08010 Barcelona, Spain., Martínez-Muñoz L; Department of Cell Signaling, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Consejo Superior de Investigaciones Cientificas, E-41092 Seville, Spain.; Department of Medical Biochemistry, Molecular Biology, and Immunology, University of Seville, Medical School, E-41004 Seville, Spain., Mellado M; Chemokine Signaling Group, Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, E-28049 Madrid, Spain.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2022 May 24; Vol. 119 (21), pp. e2119483119. Date of Electronic Publication: 2022 May 19.
Autor:
Cáceres-Martell Y; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Fernández-Soto D; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Campos-Silva C; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., García-Cuesta EM; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Casasnovas JM; Department of Macromolecular Structures, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Navas-Herrera D; Immunostep, S.L. Salamanca, Spain., Beneítez-Martínez A; Immunostep, S.L. Salamanca, Spain., Martínez-Fleta P; Immunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain., Alfranca A; Immunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain.; CIBER Cardiovascular Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain., Sánchez-Madrid F; Immunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain.; CIBER Cardiovascular Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain., Escudero-López G; Internal Medicine Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain., Vilches C; Immunology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain., Jara-Acevedo R; Immunostep, S.L. Salamanca, Spain., Reyburn HT; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Rodríguez-Frade JM; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain., Valés-Gómez M; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
Publikováno v:
European journal of immunology [Eur J Immunol] 2021 Nov; Vol. 51 (11), pp. 2633-2640. Date of Electronic Publication: 2021 Aug 19.
Autor:
D'Agostino G; Dept. Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Campus Cantoblanco, E-28049, Madrid, Spain., García-Cuesta EM; Dept. Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Campus Cantoblanco, E-28049, Madrid, Spain., Gomariz RP; Dept. Cell Biology, Complutense University of Madrid, Research Institute Hospital 12 de Octubre (i+12), E-28041, Madrid, Spain., Rodríguez-Frade JM; Dept. Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Campus Cantoblanco, E-28049, Madrid, Spain., Mellado M; Dept. Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Darwin 3, Campus Cantoblanco, E-28049, Madrid, Spain. Electronic address: mmellado@cnb.csic.es.
Publikováno v:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Jul 23; Vol. 528 (2), pp. 347-358. Date of Electronic Publication: 2020 Mar 05.
Autor:
García-Cuesta EM; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., Santiago CA; Macromolecular X-Ray Crystallography Unit, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., Vallejo-Díaz J; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., Juarranz Y; Department Cell Biology, Research Institute Hospital 12 de Octubre (i+12), Complutense University of Madrid, Madrid, Spain., Rodríguez-Frade JM; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain., Mellado M; Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain.
Publikováno v:
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Aug 27; Vol. 10, pp. 585. Date of Electronic Publication: 2019 Aug 27 (Print Publication: 2019).
Autor:
Ashiru O; Division of Bacteriology, Medicines and Healthcare products Regulatory Agency-National Institute for Biological Standards and Control (MHRA-NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK., Esteso G; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain., García-Cuesta EM; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain., Castellano E; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain.; Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain., Samba C; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain., Escudero-López E; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain., López-Cobo S; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain., Álvarez-Maestro M; Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain.; Urology Unit, Infanta Sofía Hospital, 28703 Madrid, Spain.; Servicio de Urología, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Linares A; Urology Unit, Infanta Sofía Hospital, 28703 Madrid, Spain., Ho MM; Division of Bacteriology, Medicines and Healthcare products Regulatory Agency-National Institute for Biological Standards and Control (MHRA-NIBSC), Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK., Leibar A; Urology Unit, Infanta Sofía Hospital, 28703 Madrid, Spain., Martínez-Piñeiro L; Hospital La Paz Institute for Health Research (IdiPAZ), Autonomous University of Madrid, 28046 Madrid, Spain.; Urology Unit, Infanta Sofía Hospital, 28703 Madrid, Spain.; Servicio de Urología, Hospital La Paz Institute for Health Research (IdiPAZ), 28046 Madrid, Spain., Valés-Gómez M; Department of Immunology and Oncology, National Centre for Biotechnology, Spanish National Research Council, 28049 Madrid, Spain. mvales@cnb.csic.es.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Jul 04; Vol. 11 (7). Date of Electronic Publication: 2019 Jul 04.